GOUTY ARTHRITIS
Clinical trials for GOUTY ARTHRITIS explained in plain language.
Never miss a new study
Get alerted when new GOUTY ARTHRITIS trials appear
Sign up with your email to follow new studies for GOUTY ARTHRITIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for tough gout cases: experimental combo targets stubborn uric acid
Disease control Recruiting nowThis study tests a new drug called AR882 combined with a standard gout medication (XOI) in 25 adults with uncontrolled gout who had severe reactions or failed uricase therapy. The goal is to lower uric acid levels below 6 mg/dL and shrink painful uric acid crystal deposits (tophi…
Matched conditions: GOUTY ARTHRITIS
Phase: PHASE2 • Sponsor: Arthrosi Therapeutics • Aim: Disease control
Last updated May 15, 2026 11:53 UTC
-
New gout pill aims to ease flare pain in days
Symptom relief Recruiting nowThis study tests whether a tablet called dapansutrile can safely reduce joint pain during an acute gout flare. About 300 adults with gout will receive either the study drug or a placebo. The main goal is to measure pain relief 72 hours after the first dose.
Matched conditions: GOUTY ARTHRITIS
Phase: PHASE2, PHASE3 • Sponsor: Olatec Therapeutics LLC • Aim: Symptom relief
Last updated May 17, 2026 07:51 UTC